Nivolumab for Resected Stage III or IV Melanoma at 9 Years
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Cutaneous Melanoma Detection and Management
Melanoma and MAPK Pathways
Publication details
- Journal / source
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Volume
- 394
- Issue
- 8
- Pages
- 832–832
- Publication date
- 18 February 2026
- Language
- EN